Slanix Alex
Net worth: - $ as of 31/05/2026
Net worth: - $ as of 31/05/2026
Slanix Paul T.
Alex is currently Director at ProMIS Neurosciences, Inc. since 2025 and Portfolio Manager & President at Ally Bridge Group (NY) LLC since 2024.
Former roles include Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker), Assistant Vice President at RBC Capital Markets LLC from 2017 to 2018, Associate Consultant at Bionest Partners LLC, Analyst at Consonance Capital Management LP from 2018 to 2020, and Senior Biotech Analyst at Tri Locum Partners LP from 2020 to 2022.
Education includes a doctorate from St. John's University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Director/Board Member | 22/10/2025 |
Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC Investment ManagersFinance Provides investment advice | President | 01/01/2024 |
| Companies | Position | End |
|---|---|---|
Tri Locum Partners LP
Tri Locum Partners LP Investment ManagersFinance Tri Locum’ Funds seeks to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy that aims to capitalize on innovation in the healthcare sector, across biotechnology, pharmaceuticals, services, and medical devices. The Funds invest primarily in equity and equity-related securities of companies within the healthcare sector in the Americas, Asia and Europe. The firm employs an investment process based on fundamental, bottom-up research to seek to identify investments that will generate attractive returns while seeking to minimize risk. They intend to overlay their investment process with a proprietary portfolio construction and risk management process that results in limited market and factor correlation. | Analyst-Equity | 01/07/2022 |
Consonance Capital Management LP
Consonance Capital Management LP Investment ManagersFinance Consonance Capital aims to deliver exceptional, uncorrelated risk-adjusted returns through investment opportunities in the publicly traded stocks of healthcare companies. The firm seeks to meet this strategy by investing in publicly traded micro-cap, small-cap and mid-cap healthcare equities. They believe the public healthcare market lends itself to an active long/short strategy. Consonance Capital is focused on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The firm seeks to identify and analyze companies trading below their intrinsic value, which may include deep value as well as growth companies. | Analyst-Equity | 01/06/2020 |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2018 |
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2017 |
Bionest Partners LLC
Bionest Partners LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets Biomarker testing machines | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bionest Partners LLC
Bionest Partners LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets Biomarker testing machines | Electronic Technology |
Consonance Capital Management LP
Consonance Capital Management LP Investment ManagersFinance Consonance Capital aims to deliver exceptional, uncorrelated risk-adjusted returns through investment opportunities in the publicly traded stocks of healthcare companies. The firm seeks to meet this strategy by investing in publicly traded micro-cap, small-cap and mid-cap healthcare equities. They believe the public healthcare market lends itself to an active long/short strategy. Consonance Capital is focused on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The firm seeks to identify and analyze companies trading below their intrinsic value, which may include deep value as well as growth companies. | Finance |
Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC Investment ManagersFinance Provides investment advice | Finance |
Tri Locum Partners LP
Tri Locum Partners LP Investment ManagersFinance Tri Locum’ Funds seeks to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy that aims to capitalize on innovation in the healthcare sector, across biotechnology, pharmaceuticals, services, and medical devices. The Funds invest primarily in equity and equity-related securities of companies within the healthcare sector in the Americas, Asia and Europe. The firm employs an investment process based on fundamental, bottom-up research to seek to identify investments that will generate attractive returns while seeking to minimize risk. They intend to overlay their investment process with a proprietary portfolio construction and risk management process that results in limited market and factor correlation. | Finance |
Select your edition
All financial news and data tailored to specific country editions